OM
Olga Maltseva Portfolio
Invests via Catalio Capital Management LP | Managed by George C. Petrocheilos, R. Jacob Vogelstein, Ph.D.
Invests via Catalio Capital Management LP
Managed by George C. Petrocheilos, R. Jacob Vogelstein, Ph.D.
Automatically Tracked
Olga Maltseva Profile
Olga Maltseva is a seasoned entrepreneur known for her innovative approach in the technology sector. With extensive experience in building and scaling tech startups, she has effectively merged strategic vision with operational excellence to drive growth. Her leadership has been pivotal in guiding companies through transformative stages, enabling them to navigate competitive landscapes successfully. Beyond her executive roles, Olga actively participates as an advisor, fostering emerging talent within the startup ecosystem while also contributing to investment dialogues focused on technology advancement and commercialization. She remains a significant figure within industry discussions centered around digital innovation.
Olga Maltseva is a seasoned entrepreneur known for her innovative approach in the technology sector. With extensive experience in building and scaling tech startups, she has effectively merged strategic vision with operational excellence to drive growth. Her leadership has been pivotal in guiding companies through transformative stages, enabling them to navigate competitive landscapes successfully. Beyond her executive roles, Olga actively participates as an advisor, fostering emerging talent within the startup ecosystem while also contributing to investment dialogues focused on technology advancement and commercialization. She remains a significant figure within industry discussions centered around digital innovation.
Investment Philosophy & Strategy
At the forefront of technology investment, Olga Maltseva embodies a vision for transformative growth through innovation. With an entrepreneurial mindset shaped by hands-on experience in building successful tech startups, she emphasizes strategic agility and operational refinement to capitalize on emerging opportunities. Her focus lies in identifying high-potential ventures that demonstrate scalability and disruptive capabilities within their respective markets. By championing new ideas and mentoring aspiring entrepreneurs, she nurtures a dynamic ecosystem conducive to technological advancement while facilitating productive dialogues around commercialization strategies. This holistic approach allows her to leverage both insights from her leadership journey and keen market awareness.
At the forefront of technology investment, Olga Maltseva embodies a vision for transformative growth through innovation. With an entrepreneurial mindset shaped by hands-on experience in building successful tech startups, she emphasizes strategic agility and operational refinement to capitalize on emerging opportunities. Her focus lies in identifying high-potential ventures that demonstrate scalability and disruptive capabilities within their respective markets. By championing new ideas and mentoring aspiring entrepreneurs, she nurtures a dynamic ecosystem conducive to technological advancement while facilitating productive dialogues around commercialization strategies. This holistic approach allows her to leverage both insights from her leadership journey and keen market awareness.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
36.92%
Gain +2.14%
Monthly
1.82%
Yearly
24.26%
Drawdown
22.23%
$510.37M
Equity
Holdings
$510.37M
Investment
$437.46M
$172.79M
Profit +$11.55M
Realized
$99.88M
Unrealized
$72.91M
Dividends
$2.28M
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
2.14%
Profit
$11.55M
Win %
60%
This Week
Compared To Last Week
Gain
0.84%
Profit
$4.26M
Win %
60%
This Month
Compared to last month
Gain
-1.94%
Profit
-$10.09M
Win %
60%
This Year
Compared to last year
Gain
-25.88%
Profit
-$132.76M
Win %
68%
KPTI Karyopharm Therapeutics Inc.
+11.22%
+$906,237.24 
GUTS Fractyl Health Inc.
+9.89%
+$393,217.61 
SNSE Sensei Biotherapeutics Inc
+8.62%
+$13,687.74 
TARA Protara Therapeutics Inc.
+7.53%
+$159,506.6 
DNTH Dianthus Therapeutics Inc.
+6.55%
+$2.81M 
QURE uniQure N.V.
+6.08%
+$800,519.08 
ATAI AtaiBeckley Inc.
+5.13%
+$38,387.31 
HTFL HeartFlow, Inc.
+4.92%
+$609,417.88 
CRVS Corvus Pharmaceuticals Inc.
+4.81%
+$497,877 
OM Outset Medical Inc.
+4.65%
+$23,655.8 
ELDN Eledon Pharmaceuticals Inc.
+4.39%
+$256,795.19 
SEPN Septarna Inc.
+4.36%
+$437,124.6 
TYRA Tyra Biosciences, Inc.
+4.28%
+$73,703.99 
DFTX Definium Therapeutics, Inc.
+3.9%
+$975,704.96 
ASND Ascendis Pharma A/S
+3.6%
+$1M 
MANE Veradermics Inc.
+2.69%
+$440,898.28 
IRON Disc Medicine Inc.
+2.23%
+$186,520.73 
NAMS NewAmsterdam Pharma Co. N.V.
+2.18%
+$55,145.64 
RARE Ultragenyx Pharmaceutical Inc.
+2.09%
+$425,738.82 
CYTK Cytokinetics, Incorporated
+2.03%
+$302,778.91 
DYN Dyne Therapeutics Inc.
+2.02%
+$102,542.53 
IMCR Immunocore Holdings plc American Depositary Receipt
+1.76%
+$42,597.76 
HYPR Hyperfine Inc.
+1.76%
+$33,001.03 
PHAT Phathom Pharmaceuticals Inc.
+1.73%
+$44,102.53 
MGX Metagenomi, Inc.
+0.8%
+$5,289.93 
SNDX Syndax Pharmaceuticals Inc.
+0.73%
+$135,677.1 
BMY Bristol-Myers Squibb Company
+0.61%
+$147,254.45 
INCY Incyte Corporation
+0.57%
+$112,902.62 
BBIO BridgeBio Pharma, Inc.
+0.29%
+$83,335.5 
GPCR Structure Therapeutics Inc.
+0.24%
+$26,840.33 
KALV KalVista Pharmaceuticals Inc.
0%
$0 
SLNO Soleno Therapeutics, Inc.
0%
$0 
TERN Terns Pharmaceuticals, Inc.
0%
$0 
ADPT Adaptive Biotechnologies Corporation
-3.36%
-$455,353.92 
BSX Boston Scientific Corporation
-1.54%
-$217,005.55 
EW Edwards Lifesciences Corporation
-1.5%
-$186,543.03 
ABVX Abivax SA ADR
-1.41%
-$67,014.06 
SUPN Supernus Pharmaceuticals Inc.
-1.08%
-$30,389.31 
NTRA NATERA INC (Common Stock) – ticker 45E
-0.93%
-$144,295.74 
GILD Gilead Sciences Inc.
-0.61%
-$126,206.85 
MLYS Mineralys Therapeutics, Inc.
-0.46%
-$48,338.41 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 199 | Longs Won 111/199 55% | Profit Factor 3.07 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.63M |
| Average Win $2.31M | Best Trade (Jun 11) $35.17M | Sharpe Ratio -84.14 |
| Average Loss -$949,249.95 | Worst Trade (Jun 12) -$10.3M | Z-Score -1.54 (88.18%) |
| Commissions $0 | Avg. Trade Length 6m 3w 5d | Expectancy $868,279.49 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.09% |
| Consecutive Losing Trades | 538 | 484 | 430 | 376 | 323 | 269 | 215 | 161 | 108 | 54 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
